Equity · Healthcare
Novartis AG (NVS) perpetual futures
NVS perpetual futures on 1 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade NVSUSDT.
Novartis AG develops, manufactures, and markets healthcare products, focusing on innovative prescription medicines for oncology, immunology, neuroscience, and cardiovascular diseases.
Price chart
Use the left and right arrow keys to inspect points on the chart.
Trading data
Perpetual market activity
1/2 live markets
Trading data
Perpetual market activity
Spot performance
Venue matrix
2 markets
Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.
Bitget
BingXTradability
Execution quality
Entry cost and depth per venue at $1k–$100k
Tradability
Execution quality
Entry cost and depth per venue at $1k–$100kNo sufficient depth · 0 of 1 venues absorb $10k
No fresh book data: Bitget
Taker execution estimate incl. approx. fees - maker fills are not guaranteed.
Best venues for this underlying
Best liquidity
-Tightest spread
NVSHighest volume
NVSFunding history
Stored venue snapshots by market
Funding history
Stored venue snapshots by marketCompany data
Company fundamentals
Updated 20m ago
Company data
Company fundamentals
More metrics
Fundamental detail
Annual + quarterlyRefreshed 20m ago
Charts: revenue, profit, cash flow & valuation
Next catalyst
Catalysts
Next catalyst
Catalysts
No unusual perp activity right now.
Research data
Analysts, filings and peer context
Research data
Analysts, filings and peer context
Estimates
6Company events
6Peer comparison
Similar listed perpsRevenue mix
PendingAnalysts
PendingOwnership
NVS-PERPFilings
PendingTranscripts
PendingCompany news
Reuters, WSJ, Bloomberg and FT first, as far as our news provider delivers them; other publishers behind the second filter. Headlines link to the publisher.No articles from Reuters, WSJ, Bloomberg or FT for this company in our feed.
FMP company data
Company intelligence
Updated: Oct 19, 2026, 09:42 AM UTC
FMP company data
Company intelligence
Company profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Chief executive
- Vasant Narasimhan
- Employees
- 75,267
- IPO date
- Nov 7, 1996
- Country
- CH
- Exchange
- New York Stock Exchange
Rating factors
- Return on equityi
- 5
- Return on assetsi
- 5
- Debt to equityi
- 1
- Price to earningsi
- 2
- Price to booki
- 1
Company press releases
Congressional disclosures
Senate
House
Market cap history
Largest fund holders
| Fund | Weight | Shares held |
|---|---|---|
| VPMAX | 0.69% | 4.3M |
| FLCO | 0.27% | 1.5M |
| VHCAX | 0.58% | 1.2M |
| BTMKX | 1.25% | 1.2M |
| FLCB | 0.03% | 1M |
| DFIV | 0.6% | 888.9K |
| DFAI | 0.65% | 783.1K |
| DFIC | 0.71% | 722.6K |
| VPCCX | 0.58% | 669.8K |
| AVDE | 0.45% | 616.9K |
| DIHP | 1.34% | 587.9K |
| DFAX | 0.62% | 518.1K |
Analyst track record
How the analysts covering NVS have done: ratings, price-target accuracy and the measured reaction after their calls.
| 12 months | 3 years | |
|---|---|---|
| Ratings | 29 | 70 |
| Analysts | 11 | 19 |
| Buy / hold / sell | 13 / 14 / 2 | 22 / 44 / 4 |
| Upgrades / downgrades / initiations | 4 / 0 / 1 | 6 / 5 / 5 |
| Price targets hit / missed | 10 / 14 (42%) | 41 / 15 (73%) |
| Avg. return after a rating (TipRanks) | -3.2% | +14.8% |
| Best / worst call | +34.3% / -18.9% | +70.9% / -18.9% |
After buy calls on this stock: median 21-day move -1.2% vs S&P 500 -4.6% (n = 20)
Latest ratings
| Date | Analyst | Call | Target | |
|---|---|---|---|---|
| Oct 12, 2026 | Sachin JainBank of America Securities | BuyMaintained | $181 | |
| Oct 6, 2026 | Thibault BoutherinMorgan Stanley | BuyMaintained | $156 | article ↗ |
| Oct 6, 2026 | Thibault BoutherinMorgan Stanley | BuyMaintained | $156 | article ↗ |
| Oct 5, 2026 | Sachin JainBank of America Securities | BuyMaintained | – | article ↗ |
| Sep 10, 2026 | Rajesh KumarHSBC | HoldUpgraded | $136 | article ↗ |
Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.
TipRanks data via FMP · computed Oct 16, 2026 · 29 ratings
Frequently asked questions
Where can I trade NVS perpetual futures?
Novartis AG (NVS) perpetual futures trade on 1 crypto venues, including Bitget. PerpEquities compares them by live price, funding rate, open interest and liquidity.
Can I trade NVS around the clock?
Yes. Unlike the underlying stock, NVS perpetuals trade 24/7 — including weekends and outside regular market hours.
What is the funding rate on NVS perpetuals?
Right now the NVS perp funding rate is 0.0% annualized (venue median), ranging from 0.0% to 0.0% across 1 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.
How does the NVS perp price compare to the Novartis AG stock?
The venue-median NVS perp mark is $150.6 versus a reference stock price of $150.6, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.
What is a NVS perpetual future?
A NVS perpetual is a derivative that tracks the price of Novartis AG with no expiry date. It lets you take long or short exposure to Novartis AG on crypto venues, around the clock.
What is NVSUSDT perpetual?
NVSUSDT is the symbol most crypto exchanges use for the Novartis AG perpetual settled in USDT (Tether). It tracks the NVS share price through an index, trades 24/7 with leverage and never expires.
Embed this asset
<a href="https://perpequities.com/stocks/nvs-perp"><img src="https://perpequities.com/badge/nvs-perp.svg" width="240" height="64" alt="NVS perpetuals · perpequities.com" loading="lazy"></a>